Nextar Chempharma Solutions is an Israel-based private biotechnology company focusing on brain and CNS treatment. Our proprietary Brain Targeted Liposomes (BTLs) platform, can facilitate targeted delivery of versatile drugs across the BBB and into the brain. Born out of Nextar, Nextage Therapeutics Ltd. develops the next generation of cannabinoid-based and psychedelic products. Nextar also serves as a CDMO and was involved in the development of over 180 innovative products.